Pros and cons of feeding the septic intensive care unit patient

Nutrition in Clinical Practice

Volumn 30, Issue 3, 2015, Pages 344-350

  Fremont, Richard D ^a   Rice, Todd W ^b  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

arginine; enteral nutrition; glutamine; nutritional support; parenteral nutrition; sepsis; 3 fatty acids

Indexed keywords

ANTIOXIDANT; ARACHIDONIC ACID; ARGININE; DOCOSAHEXAENOIC ACID; GLUTAMINE; ICOSAPENTAENOIC ACID; LEUKOTRIENE; LIPOXYGENASE; OMEGA 3 FATTY ACID; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTIFICIAL FEEDING; AUTOPHAGY; CALORIC INTAKE; CLINICAL PRACTICE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; ENTERIC FEEDING; FAT INTAKE; HEALTH CARE COST; HUMAN; HYPERGLYCEMIA; INFECTIOUS COMPLICATION; INTENSIVE CARE; INTENSIVE CARE UNIT; MALNUTRITION; NUTRITIONAL STATUS; OVERNUTRITION; OXIDATIVE STRESS; PARENTERAL NUTRITION; PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN DEGRADATION; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; META ANALYSIS (TOPIC); PROCEDURES;

ARGININE; CRITICAL ILLNESS; ENTERAL NUTRITION; FATTY ACIDS, OMEGA-3; GLUTAMINE; HUMANS; INTENSIVE CARE UNITS; META-ANALYSIS AS TOPIC; NUTRITIONAL STATUS; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS;

EID: 84930343248     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533615578457     Document Type: Review

References (51)

1. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013 2063 ; 369 ( 21 ):
2. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013 ; 39 (2). 165-228
3. Pontes-Arruda A, Martins LF, de Lima SM, et al. Enteral nutrition with eicosapentaenoic acid, Î-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study. Crit Care. 2011 ; 15 (3). R144
4. Rice TW, Wheeler AP, et al. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA. 2012 ; 307 (8). 795-803
5. Rice TW, Mogan S, Hays MA, et al. Randomized trial of initial trophic versus full-energy enteral nutrition in mechanically ventilated patients with acute respiratory failure. Crit Care Med. 2011 ; 39 (5). 967-974
6. Needham DM, Dinglas VD, Bienvenu OJ, et al. One year outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: prospective follow-up of EDEN randomised trial. BMJ. 2013 ; 346: f1532
7. Doig GS, Simpson F, Sweetman EA, et al. Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a randomized controlled trial. JAMA. 2013 ; 309 (20). 2130-2138
8. Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011 ; 365 (6). 506-517
9. Elke G, Wang M, Weiler N, Day AG, Heyland DK. Close to recommended caloric and protein intake by enteral nutrition is associated with better clinical outcome of critically ill septic patients: secondary analysis of a large international nutrition database. Crit Care. 2014 ; 18 (2). R29
10. Moore EE, Jones TN. Benefits of immediate jejunostomy feeding after major abdominal trauma - a prospective, randomized study. J Trauma. 1986 ; 26 (10). 874-881
11. Chiarelli A, Enzi G, Casadei A, et al. Very early nutrition supplementation in burned patients. Am J Clin Nutr. 1990 ; 51 (6). 1035-1039
12. McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2009 ; 33 (3). 277-316
13. Singer P, Berger MM, Van den Berghe G, et al. ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr. 2009 ; 28 (4). 387-400
14. Hernandez G, Velasco N, Wainstein C, et al. Gut mucosal atrophy after a short enteral fasting period in critically ill patients. J Crit Care. 1999 ; 14 (2). 73-77
15. Hadfield RJ, Sinclair DG, Houldsworth PE, Evans TW. Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med. 1995 ; 152 (5, pt 1). 1545-1548
16. McClure RJ, Newell SJ. Randomised controlled study of clinical outcome following trophic feeding. Arch Dis Child Fetal Neonatal Ed. 2000 ; 82 (1). F29 - F33
17. Zaloga GP, Black KW, Prielipp R. Effect of rate of enteral nutrient supply on gut mass. JPEN J Parenter Enteral Nutr. 1992 ; 16 (1). 39-42
18. Doig GS, Heighes PT, Simpson F, et al. Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials. Intensive Care Med. 2009 ; 35 (12). 2018-2027
19. Marik PE, Zaloga GP. Early enteral nutrition in acutely ill patients: a systematic review. Crit Care Med. 2002 ; 30 (3). 725
20. Harvey SE, Parrott F, Harrison DA, et al. Trial of the route of early nutritional support in critically ill adults. N Engl J Med. 2014 ; 371 (18). 1673-1684
21. Needham DM, Dinglas VD, Bienvenu OJ, et al. One year outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: prospective follow-up of EDEN randomised trial. BMJ. 2013 ; 346: f1532
22. Braunschweig CA, Sheean PM, Peterson SJ, et al. Intensive nutrition in acute lung injury: a clinical trial (INTACT). JPEN J Parenter Enteral Nutr. 2015 ; 39 (1). 13-20
23. Calder PC. N-3 fatty acids, inflammation, and immunity - relevance to postsurgical and critically ill patients. Lipids. 2004 ; 39 (12). 1147-1161
24. Prescott SM, Stenson WF. Fish oil fix. Nat Med. 2005 ; 11 (6). 596-598
25. Lelcuk S, Huval WV, Valeri CR, Shepro D, Hechtman HB. Inhibition of ischemia-induced thromboxane synthesis in man. J Trauma. 1984 ; 24 (5). 393-396
26. Pontes-Arruda A, Demichele S, Seth A, Singer P. The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data. JPEN J Parenter Enteral Nutr. 2008 ; 32 (6). 596-605
27. Galban C, Montejo JC, Mesejo A, et al. An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med. 2000 ; 28 (3). 643-648
28. Beale RJ, Sherry T, Lei K, et al. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial. Crit Care Med. 2008 ; 36 (1). 131-144
29. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med. 1999 ; 27 (8). 1409-1420
30. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006 ; 34 (4). 1033-1038
31. Rice TW, Wheeler AP, Thompson BT, et al. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA. 2011 ; 306 (14). 1574-1581
32. Van Zanten AR, Sztark F, Kaisers UX, et al. High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA. 2014 ; 312 (5). 514-524
33. Hall TC, Bilku DK, Al-Leswas D, et al. A randomized controlled trial investigating the effects of parenteral fish oil on survival outcomes in critically ill patients with sepsis: a pilot study. JPEN J Parenter Enteral Nutr. 2015 ; 39 (3). 301-312
34. Grau-Carmona T, Bonet-Saris A, Garcia-de-Lorenzo A, et al. Influence of n-3 polyunsaturated fatty acids enriched lipid emulsions on nosocomial infections and clinical outcomes in critically ill patients: ICU Lipids Study. Crit Care Med. 2015 ; 43: 31-39
35. Wohlmuth C, Dunser MW, Worzinger B, et al. Early fish oil supplementation and organ failure in patients with septic shock from abdominal infections: a propensity-matched cohort study. JPEN J Parenter Enteral Nutr. 2010 ; 34 (4). 431-437
36. Palmer AJ, Ho CK, Ajibola O, Avenell A. The role of omega-3 fatty acid supplemented parenteral nutrition in critical illness in adults: a systematic review and meta-analysis. Crit Care Med. 2013 ; 41 (1). 307-316
37. Pradelli L, Mayer K, Muscaritoli M, Heller AR. N-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysis. Crit Care. 2012 ; 16 (5). R184
38. Chen W, Jiang H, Zhou ZY, et al. Is omega-3 fatty acids enriched nutrition support safe for critical ill patients? A systematic review and meta-analysis. Nutrients. 2014 ; 6 (6). 2148-2164
39. Kao CC, Bandi V, Guntupalli KK, Wu M, Castillo L, Jahoor F. Arginine, citrulline and nitric oxide metabolism in sepsis. Clin Sci (Lond). 2009 ; 117 (1). 23-30
40. Gough MS, Morgan MA, Mack CM, et al. The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis. Crit Care Med. 2011 ; 39 (6). 1351-1358
41. Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003 ; 27 (5). 355-373
42. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med. 2002 ; 30: 2022-2029
43. Andrews PJ, Avenell A, Noble DW, et al. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ. 2011 ; 342: d1542
44. Wernerman J, Kirketeig T, Andersson B, et al. Scandinavian glutamine trial: a pragmatic multi-centre randomised clinical trial of intensive care unit patients. Acta Anaesthesiol Scand. 2011 ; 55 (7). 812-818
45. Heyland DK, Muscedere J, Wischmeyer P, et al. A randomized trial of glutamine and antioxidants in critically ill patients (REDOXS). N Engl J Med. 2013 ; 368: 1489-1497
46. Wischmeyer PE, Dhaliwal R, McCall M, Ziegler TR, Heyland DK. Parenteral glutamine supplementation in critical illness: a systematic review. Crit Care. 2014 ; 18 (2). R76
47. Luiking YC, Poeze M, Ramsay G, Deutz NE. Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production. Am J Clin Nutr. 2009 ; 89 (1). 142-152
48. Liuking YC, Poeze M, Deutz NE. Arginine infusion in patients with septic shock increases nitric oxide production without haemodynamic instability. Clin Sci. 2015 ; 128 (1). 57-67
49. Visser M, Vermeulen MA, Richir MC, et al. Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients. Br J Nutr. 2012 ; 107 (10). 1458-1465
50. Schetz M, Casaer MP, Van den Berghe G. Does artificial nutrition improve outcome of critical illness?. Crit Care. 2013 ; 17 (1). 302-307
51. Casaer MP, Wilmer A, Hermans G, et al. Role of disease and macronutrient dose in the randomized controlled EPaNIC trial: a post hoc analysis. Am J Respir Crit Care Med. 2013 ; 187 (3). 247-255